We describe the case of a female patient, 21 years old, complaining of dyspnea attacks and wheezing 2 years ago. Chest radiography showed volume loss in the left lower lobe and ipsilateral retrocardiac triangular basal opacity. CT scan showed an extensive solid mass with apex protruding into the left main and lower lobar bronchi, causing distal atelectasis. Histopathological and immunohistochemical study of transbronchial biopsy of the lesion revealed a typical carcinoid tumor, confirmed after tumor resection with total left pneumectomy.
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case report A female 21-year old patient presenting dyspnea and wheezing attacks for two years. She is overweight, has polycystic ovary syndrome and is currently using oral contraceptives. She does not smoke. The patient reported that three radiographs in the past 6 months revealed consolidation in the left lung base. During this period, treatment regimens for pneumonia were used, without clinical or radiological improvement. On auscultation, rhonchi and wheezing were audible at the base of the left hemithorax. Laboratory tests did not point out any abnormalities.
A new chest X-ray showed loss of volume in the left lower lobe with triangular basal retrocardiac opacity, apex directed towards the ipsilateral hilum and base next to the diaphragmatic dome ( Figures 1A and 1B) .
Computed tomography (CT) imaging showed a solid expansive mass with apex protruding into the left source bronchus ("tip of the iceberg" sign 1 ), causing partial obstruction and distal subsegmentar atelectasis, as well as marked enhancement following intravenous contrast administration (Figures 2A, 2B, 2C and 2D) .
After bronchofibroscopy, which confirmed the endobronchial lesion, the anatomopathological and immunohistochemical investigation of the transbronchial biopsy material showed a well-differentiated (typical) carcinoid tumor ( Figures 3A, 3B and 3C). A CT scan of the abdomen performed for staging failed to show other neoplastic formations. The therapy selected was left total pneumonectomy, which confirmed the histological finding of tumor in a subsequent investigation.
discussion
Carcinoid tumors (CATUs) are neuroendocrine neoplasms originating from enterochromaffin cells, commonly found in the gastrointestinal tract. Occurrence in the respiratory tract corresponds to 10-30% of all cases, 1-6 with a bronchopulmonary incidence of 0.22 to 1.57/100,000. [2] [3] [4] They represent up to 2% of lung malignancies, 1,2 often presenting indolent behavior. [1] [2] [3] 5 Histologically, these tumors are classified as typical (76-90%) or atypical. [1] [2] [3] [4] Central bronchial CATUs represent 64-85% of the cases, with a predominance of typical tumors. [1] [2] [3] Typical CATUs affect both sexes, [1] [2] [3] with some studies reporting a higher prevalence in women.
2,3 They have two peaks of incidence: one in adolescence and another near the age of 45 years. 1 Metastases occur in 15%. 1 Symptoms are more frequent in tumors at central sites and some of the main manifestations include recurrent pneumonia, chest pain, cough, hemoptysis and localized wheezing. [1] [2] [3] 6, 7 These tumors can secrete neuroamines and peptide hormones, especially serotonin, growth hormone and adrenocorticotrophic hormone, and may cause carci- 
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noid syndrome, acromegaly and Cushing's disease (2%), especially in the presence of metastases, with an emphasis on the liver as site of secondary implantation.
1,3
Radiographs generally reveal well-defined hilar/perihilar masses, rounded or ovoid in shape, associated or not with distal parenchymal disease, such as consolidations or atelectasis. It is rarely possible to distinguish an endoluminal component, with extension to the parenchyma being the most dominant feature. [1] [2] [3] [7] [8] [9] On CT scan, the presence of two central sites is common (85% in the main, lobar or segmental bronchi), with an appearance of nodule or ovoid mass, well-defined and regular margins, spontaneously hyperdense, associated or not with a distinct endoluminal component or distal parenchymal complications. Punctual or diffuse calcifications are found in 30% of the cases. The stroma in these tumors is typically well-vascularized with homogeneous and intense contrast enhancement. [1] [2] [3] [7] [8] [9] Despite the primarily endoluminal origin, it is typically observed on CT that most of the mass extends to the adjacent parenchyma, and the endoluminal component may be minimal. This finding is what is called the "tip of the iceberg" sign. 1, 8, 9 Prognosis is most often favorable and varies with the typical or atypical character of the lesion, tumor resectability, lymphatic or metastatic dissemination. For staging purposes, the TNM protocol is used for lung neoplasms, and stage I, II and IIIA tumors are considered resectable. [1] [2] [3] [7] [8] [9] In cases of localized neoplasia, both in the typical and atypical forms, the treatment of choice is tumor resection, with a tendency to preserve as much healthy lung tissue as possible. 2, 10, 11 Survival rates for the typical and atypical forms 5 and 10 years after surgery are 90% and 80%, and 70% and 50%, respectively. 10 In advanced disease, however, this therapeutic alternative is contraindicated, as there is no evidence that extended surgery can improve the prognosis, 11 which leaves the option of using somatostatin analogs for disease stabilization. 10 In the case of hepatic and lymph node metastases, surgical removal of tumors is primarily intended to relieve symptoms. 1, 10 The use of adjuvant chemotherapy and radiotherapy is controversial in the literature 10, 11 and there is no consensus. Nevertheless, there are reports of patients with atypical carcinoid tumors who would benefit from these treatments. 11 resuMo Tumor carcinoide endobrônquico: aspectos radiológicos em um caso clínico Descrevemos um caso de paciente do gênero feminino, 21 anos, apresentando crises de dispneia e sibilância há 2 anos. Radiografia torácica evidenciou perda volumétrica do lobo inferior esquerdo e opacidade triangular basal retrocardíaca ipsilateral. Tomografia computadorizada mostrou formação expansiva sólida com ápice protruindo para o interior dos brônquios principal e lobar inferior esquerdos, promovendo atelectasia distal. Estudos anatomopatoló-gico e imuno-histoquímico após biópsia transbrônquica da lesão diagnosticaram um tumor carcinoide típico, confirmado após ressecção tumoral com pneumectomia total esquerda. references
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